Lack of relationship between 174G-C promoter polymorphism of the IL-6 gene and indices of metabolic syndrome in non-obese healthy subjects

Endokrynologia Polska

Volumn 60, Issue 3, 2009, Pages 172-179

  Tworowska Bardzińska, Urszula ^a   Kubicka, Eliza ^a   Ślȩzak, Ryszard ^b   Mielcarek, Monika ^b   Bednarek Tupikowska, Grazyna ^a   Bolanowski, Marek ^a   Milewicz, Andrzej ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b UNIVERSITY OF WROC AW   (Poland)

Author keywords

Fat distribution; IL 6 174G C promoter polymorphism; Insulin resistance; Insulin sensitivity; Metabolic syndrome

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6;

ABDOMINAL FAT; ADULT; ANTHROPOMETRY; ARTICLE; ATHEROMATOSIS; BODY FAT DISTRIBUTION; BODY MASS; CONTROLLED STUDY; DNA POLYMORPHISM; DUAL ENERGY X RAY ABSORPTIOMETRY; FAT CONTENT; FEMALE; GENETIC ANALYSIS; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN EXPERIMENT; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; METABOLIC SYNDROME X; NORMAL HUMAN; POLAND; PROMOTER REGION; RISK FACTOR; STATISTICAL SIGNIFICANCE; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

EID: 67749135494     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Kubaszek A, Pihlajamaki J, Punnonen K et al. The C-174G promoter polymorphism of the IL-6 gene affects energy expenditure and insulin sensitivity. Diabetes 2003; 52: 558-561. (Pubitemid 36173216)
2. Mohlig M, Boeing H, Spranger J et al. Body mass index and C-174G interleukin-6 promoter polymorphism interact in predicting type 2 diabetes. J Clin Endocrinol Metab 2004; 89: 1885-1890. (Pubitemid 38507949)
3. Klipstein-Grobusch K, Mohlig M, Spranger J et al. Interleukin-6 g.-174G>C Promoter Polymorphism Is Associated with Obesity in the EPIC-Potsdam Study. Obesity 2006; 14: 14-18. (Pubitemid 46214770)
4. Berthier MT, Paradis AM, Tchernof A et al. The interleukin 6-174G/C polymorphism is associated with indices of obesity in men. J Hum Genet 2003; 48: 14-19. (Pubitemid 36205641)
5. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
6. Katz A, Nambi SS, Mather K et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85: 2402-2410. (Pubitemid 32269192)
7. Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and B cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419. (Pubitemid 15018832)
8. Duncan MH, Singh BM, Wise PH et al. A simple measure of insulin resistance. Lancet 1995; 346: 120-121.
9. Fishman D, Faulds G, Jeffery R et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998; 102: 1369-1376. (Pubitemid 28467565)
10. Nauck M, Winkelmann BR, Hoffmann MM et al. The interleukin-6 G(-174)C promoter polymorphism in the LURIC cohort: no association with plasma interleukin-6, coronary artery disease, and myocardial infarction. J Mol Med 2002; 80: 507-513.
11. Illig T, Bongardt F, Schopfer A et al. Cooperative Research in the Region of Augsburg. Significant association of the interleukin-6 gene polymorphisms C-174G and A-598G with type 2 diabetes. J Clin Endocrinol Metab 2004; 89: 5053-5058.
12. Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 2000;275: 18138-18144. (Pubitemid 30414764)
13. Kilpinen S, Hulkkonen J, Wang XY et al. The promoter polymorphism of the interleukin-6 gene regulates interleukin-6 production in neonates but not in adults. Eur Cytokine Netw 2001; 12: 62-68. (Pubitemid 32281191)
14. Brull DJ, Montgomery HE, Sanders J et al. Interleukin-6 gene -174g>c and -572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol 2001; 21: 1458-1463. (Pubitemid 34219808)
15. Yang X, Jansson PA, Pellme F et al. Effect of the interleukin-6 (-174) G/C promoter polymorphism on adiponectin and insulin sensitivity. Obes Res 2005; 13: 813-817.
16. Mohamed-Ali V, Goodrick S, Rawesh A et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997; 82: 4196-4200. (Pubitemid 27525539)
17. Henningsson S, Hakansson A, Westberg L et al. Interleukin-6 gene polymorphism -174G/C influences plasma lipid levels in women. Obesity 2006; 14: 1868-1873. (Pubitemid 46121915)
18. Cardellini M, Perego L, D'Adamo M et al. C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance. Diabetes Care 2005; 28: 2007-2012. (Pubitemid 41060976)
19. Sesti G, Perego L, Cardellini M et al. Impact of Common Polymorphisms in Candidate Genes for Insulin Resistance and Obesity on Weight Loss of Morbidly Obese Subjects after Laparoscopic Adjustable Gastric Banding and Hypocaloric Diet. J Clin Endocrinol Metab 2005; 90: 5064-5069. (Pubitemid 41262255)
20. Catalan V, Gómez-Ambrosi J, Ramirez B et al. Proinflammatory cytokines in obesity: impact of type 2 diabetes mellitus and gastric bypass. Obes Surg 2007; 17: 1464-1474.
21. Herder C, Schneitler S, Rathmann W et al. Low-grade inflammation, obesity, and insulin resistance in adolescents. J Clin Endocrinol Metab 2007; 92: 4569-4574. (Pubitemid 350223428)
22. Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004; 27: 813-823.
23. Bastard JP, Maachi M, Tran Van Nhieu J et al. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 2002; 87: 2084-2089. (Pubitemid 34521492)
24. Fernandez-Real JM, Vayreda M, Richart C et al. Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab 2001; 86: 1154-1159. (Pubitemid 32322997)
25. Bastard JP, Maachi M, Lagathu C et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006; 7: 4-12.